Oral appliances in the treatment of obstructive sleep apnea syndrome

  • Ivan Kopitović Institute for Pulmonary Diseases of Vojvodina, Faculty of Medicine, University of Novi Sad, Sremska Kamenica, Serbia
  • Sandra Pjevac Specialized Office for Maxillofacial Surgery "Prof. dr Džolev", Novi Sad, Serbia
  • Milica Mirić Institute for Pulmonary Diseases of Vojvodina, Faculty of Medicine, University of Novi Sad, Sremska Kamenica, Serbia
  • Dragana Miličić Institute for Pulmonary Diseases of Vojvodina, Faculty of Medicine, University of Novi Sad, Sremska Kamenica, Serbia
  • Marija Vukoja Institute for Pulmonary Diseases of Vojvodina, Faculty of Medicine, University of Novi Sad, Sremska Kamenica, Serbia
Keywords: sleep apnea, obstructive, orthodontic appliances, treatment outcome,

References

Kopitović I. Respiratory disorders during sleep. Novi Sad: Facul-ty of Medicine, University of Novi Sad; 2011. (Serbian)

Kopitovic I, Trajanovic N, Prodic S, Drvenica MJ, Ilic M, Kuruc V, et al. The Serbian version of the Epworth Sleepiness Scale. Sleep Breath 2011; 15(4): 775−80.

Tkacova R, Dorkova Z. Clinical presentations of OSA in adults. Eur Respir Mon 2010; 50: 86−103.

Itasaka Y, Miyazaki S, Ishikawa K, Togawa K. Intensity of snor-ing in patients with sleep-related breathing disorders. Psychia-try Clin Neurosci 1999; 53(2): 299−300.

Lavie L. Oxidative stress and inflammation in OSA. Eur Respir Mon 2010; 50: 360−80.

Almendros I, Montserrat JM, Ramírez J, Torres M, Duran-Cantolla J, Navajas D, et al. Intermittent hypoxia enhances cancer pro-gression in a mouse model of sleep apnoea. Eur Respir J 2012; 39(1): 215−7.

Shamsuzzaman A, Amin RS, Calvin AD, Davison D, Somers VK. Severity of obstructive sleep apnea is associated with elevated plasma fibrinogen in otherwise healthy patients. Sleep Breath 2014; 18(4): 761−6.

Bonsignore MR, Battaglia S, Zito A, Lombardi C, Parati G. Sleep apnoea and systemic hypertension. Eur Respir Mon 2010; 50: 150−73.

Kendzerska T, Gershon AS, Hawker G, Leung RS, Tomlinson G. Obstructive Sleep Apnea and Risk of Cardiovascular Events and All-Cause Mortality: A Decade-Long Historical Cohort Study. PLoS Med 2014;11(2) e1001599.

Gami AS, Olson EJ, Shen WK, Wright SR, Ballman KV, Hodge DO, et al. Obstructive sleep apnea and the risk of sudden car-diac death: a longitudinal study of 10,701 adults. J Am Coll Cardiol 2013; 62(7): 610−6.

Kopitović I, Anđelić B, Jovančević-Drvenica M. Comparing parame-ters of screening polysomography and excessive day time sleepiness in sleep apnea syndrome. Scr Med 2008; 1(39): 9−12. (Serbian)

Kopitovic I, Kojicic M, Drvenica JM, Ilic M. Laba in patients with stage 1 COPD and mild sleep apnea: A pilot study. Cent Eur J Med 2011; 6(1): 26−30.

Kopitović I, Jovančević-Drvenica M, Vukoja M, Okiljević Z. Breathing disorder during sleep. Časopis udruženja pulmologa Republike Srpske 2011; 11(1): 310−5. (Serbian)

Punjabi NM, Shahar E, Redline S, Gottlieb DJ, Givelber R, Resnick HE. Sleep-disordered breathing, glucose intolerance, and insu-lin resistance: The Sleep Heart Health Study. Am J Epidemiol 2004; 160(6): 521−30.

Marin JM, Soriano JB, Carrizo SJ, Boldova A, Celli BR. Outcomes in patients with chronic obstructive pulmonary disease and obstructive sleep apnea: The overlap syndrome. Am J Respir Crit Care Med 2010; 182(3): 325−31.

Byrne TJ, Parish JM, Somers V, Aqel BA, Rakela J. Evidence for liver injury in the setting of obstructive sleep apnea. Ann Hepatol 2012; 11(2): 228−31.

Durgan DJ, Bryan RM. Cerebrovascular consequences of ob-structive sleep apnea. J Am Heart Assoc 2012; 1(4): e000091.

Harris M, Glozier N, Ratnavadivel R, Grunstein RR. Obstructive sleep apnea and depression. Sleep Med Rev 2009; 13(6): 437−44.

Hoffstein V. Review of oral appliances for treatment of sleep-disordered breathing. Sleep Breath 2007; 11(1): 1−22.

Gaudette E, Kimoff RJ. Pathophysiology of OSA. Eur Respir Monogr 2010; 50: 31−50.

Kuna S, Remmers JE. Anatomy and physiology of upper airway obstruction. In: Kryger MH, Roth T, Dement WC, editors. Prin-ciples and Practice of Sleep Medicine. 3rd ed. London: WB Saunders; 2000. p. 840−58.

Verbraecken JA, De Backer WA. Upper airway mechanics. Res-piration 2009; 78(2): 121−33.

Randerath WJ, Verbraecken J, Andreas S, Bettega G, Boudewyns A, Hamans E, et al. Non-CPAP therapies in obstructive sleep ap-noea. Eur Respir J 2011; 37(5): 1000−28.

Sullivan CE, Issa FG, Berthon-Jones M, Eves L. Reversal of ob-structive sleep apnoea by continuous positive airway pressure applied through the nares. Lancet 1981; 1(8225): 862−5.

Cartwright RD, Samelson CF. The effects of a nonsurgical treat-ment for obstructive sleep apnea. The tongue-retaining device. JAMA 1982; 248(6): 705−9.

Fleetham JA, Almeida FR. Oral appliances. Eur Respir Mon 2010; 50: 267−85.

Cistulli PA, Gotsopoulos H, Marklund M, Lowe AA. Treatment of snoring and obstructive sleep apnea with mandibular reposi-tioning appliances. Sleep Med Rev 2004; 8(6): 443−57.

Ng AT, Gotsopoulos H, Qian J, Cistulli PA. Effect of oral appli-ance therapy on upper airway collapsibility in obstructive sleep apnea. Am J Respir Crit Care Med 2003; 168(2): 238−41.

Kyung SH, Park Y, Pae E. Obstructive sleep apnea patients with the oral appliance experience pharyngeal size and shape changes in three dimensions. Angle Orthod 2005; 75(1): 15−22.

Gale DJ, Sawyer RH, Woodcock A, Stone P, Thompson R, Brien OK. Do oral appliances enlarge the airway in patients with obstruc-tive sleep apnoea? A prospective computerized tomographic study. Eur J Orthod 2000; 22(2): 159−68.

Sanner BM, Heise M, Knoben B, Machnick M, Laufer U, Kikuth R, et al. MRI of the pharynx and treatment efficacy of a mandibular advancement device in obstructive sleep apnoea syndrome. Eur Respir J 2002; 20(1): 143−50.

Chan AS, Sutherland K, Schwab RJ, Zeng B, Petocz P, Lee RW, et al. The effect of mandibular advancement on upper airway structure in obstructive sleep apnoea. Thorax 2010; 65(8): 726−32.

Ryan CF, Love LL, Peat D, Fleetham JA, Lowe AA. Mandibular advancement oral appliance therapy for obstructive sleep ap-noea: effect on awake calibre of the velopharynx. Thorax 1999; 54(11): 972−7.

Lazard DS, Blumen M, Lévy P, Chauvin P, Fragny D, Buchet I, et al. The tongue-retaining device: efficacy and side effects in ob-structive sleep apnea syndrome. J Clin Sleep Med 2009; 5(5): 431−8.

Naismith SL, Winter VR, Hickie IB, Cistulli PA. Effect of oral appliance therapy on neurobehavioral functioning in obstruc-tive sleep apnea: a randomized controlled trial. J Clin Sleep Med 2005; 1(4): 374−80.

Barnes M, McEvoy DR, Banks S, Tarquinio N, Murray CG, Vowles N, et al. Efficacy of positive airway pressure and oral appliance in mild to moderate obstructive sleep apnea. Am J Respir Crit Care Med 2004; 170(6): 656−64.

Gotsopoulos H, Kelly JJ, Cistulli PA. Oral appliance therapy re-duces blood pressure in obstructive sleep apnea: a ran-domized, controlled trial. Sleep 2004; 27(5): 934−41.

Yoshida K. Effect on blood pressure of oral appliance therapy for sleep apnea syndrome. Int J Prosthodont 2006; 19(1): 61−6.

Hoekema A, Voors AA, Wijkstra PJ, Stegenga B, Hoeven JH, Tol CG, et al. Effects of oral appliances and CPAP on the left ven-tricle and natriuretic peptides. Int J Cardiol 2008; 128(2): 232−9.

Trzepizur W, Gagnadoux F, Abraham P, Rousseau P, Meslier N, Saumet J, et al. Microvascular endothelial function in obstruc-tive sleep apnea: Impact of continuous positive airway pres-sure and mandibular advancement. Sleep Med 2009; 10(7): 746−52.

Itzhaki S, Dorchin H, Clark G, Lavie L, Lavie P, Pillar G. The ef-fects of 1-year treatment with a herbst mandibular advance-ment splint on obstructive sleep apnea, oxidative stress, and endothelial function. Chest 2007; 131(3): 740−9.

Coruzzi P, Gualerzi M, Bernkopf E, Brambilla L, Brambilla V, Broia V, et al. Autonomic cardiac modulation in obstructive sleep apnea: effect of an oral jaw-positioning appliance. Chest 2006; 130(5): 1362−8.

White D, Shafazand S. Mandibular Advancement Device vs CPAP in the Treatment of Obstructive Sleep Apnea: Are they Equally Effective in Short Term Health Outcomes. J Clin Sleep Med 2013; 9(9): 2013−5.

Mehta A, Qian J, Petocz P, Darendeliler MA, Cistulli PA. A ran-domized, controlled study of a mandibular advancement splint for obstructive sleep apnea. Am J Respir Crit Care Med 2001; 163(6): 1457−61.

Gotsopoulos H, Chen C, Qian J, Cistulli PA. Oral appliance therapy improves symptoms in obstructive sleep apnea: a randomized, controlled trial. Am J Respir Crit Care Med 2002; 166(5): 743−8.

Ferguson KA, Cartwright R, Rogers R, Schmidt-Nowara W. Oral ap-pliances for snoring and obstructive sleep apnea: A review. Sleep 2006; 29(2): 244−62.

Ferguson KA, Ono T, Lowe AA, al-Majed S, Love LL, Fleetham JA. A short-term controlled trial of an adjustable oral appliance for the treatment of mild to moderate obstructive sleep apnoea. Thorax 1997; 52(4): 362−8.

Estrange LP, Battagel JM, Harkness B, Spratley MH, Nolan PJ, Jor-gensen GI. A method of studying adaptive changes of the oro-pharynx to variation in mandibular position in patients with obstructive sleep apnoea. J Oral Rehabil 1996; 23(10): 699−711.

Fritsch KM, Iseli A, Russi EW, Bloch KE. Side effects of man-dibular advancement devices for sleep apnea treatment. Am J Respir Crit Care Med 2001; 164(5): 813−8.

Pantin CC, Hillman DR, Tennant M. Dental side effects of an oral device to treat snoring and obstructive sleep apnea. Sleep 1999; 22(2): 237−40.

Marklund M, Sahlin C, Stenlund H, Persson M, Franklin KA. Mandibular advancement device in patients with obstructive sleep apnea : Long-term effects on apnea and sleep. Chest 2001; 120(1): 162−9.

Marklund M, Franklin KA, Persson M. Orthodontic side-effects of mandibular advancement devices during treatment of snor-ing and sleep apnoea. Eur J Orthod 2001; 23(2): 135−44.

Bondemark L, Lindman R. Craniomandibular status and function in patients with habitual snoring and obstructive sleep apnoea after nocturnal treatment with a mandibular advancement splint: A 2-year follow-up. Eur J Orthod 2000; 22(1): 53−60.

Rose EC, Staats R, Virchow C, Jonas IE. Occlusal and skeletal ef-fects of an oral appliance in the treatment of obstructive sleep apnea. Chest 2002; 122(3): 871−7.

FDA Class II Special Controls Guidance Document: Intraoral Devices for Snoring and/or Obstructive Sleep Apnea; Guid-ance for Industry and FDA. 2013. Available from: https://www.accessdata.fda.gov/.../cfdocs/.../classi.

American Sleep Disorders Association. Practice parameters for the treatment of snoring and obstructive sleep apnea with oral ap-pliances. Sleep 1995; 18(6): 511−3.

Pitsis AJ, Darendeliler AM, Gotsopoulos H, Petocz P, Cistulli PA. Effect of vertical dimension on efficacy of oral appliance ther-apy in obstructive sleep apnea. Am J Respir Crit Care Med 2002; 166(6): 860−4.

Published
2017/06/21
Section
Review Paper